Overview of the most common biologic medications used to treat rheumatoid arthritis, including TNF Alpha inhibitors, IL-6 inhibitors, CD20 inhibitors, and JAK inhibitors.
Key Takeaways
- TNF Alpha inhibitors are the most commonly used biologics for rheumatoid arthritis.
- IL-6 inhibitors and CD20 inhibitors provide alternative mechanisms of action.
- JAK inhibitors represent a newer class of oral medications for rheumatoid arthritis.
- Knowing the medication classes helps in understanding treatment options.
- Biologics target specific immune system components to reduce arthritis inflammation.
Summary
- The video discusses common biologic medications for rheumatoid arthritis treatment.
- TNF Alpha inhibitors include adalimumab (Humira), etanercept (Enbrel), golimumab (Simponi), certolizumab (Cimzia), and infliximab (Remicade).
- IL-6 inhibitors mentioned are tocilizumab (Actemra) and sarilumab (Kevzara).
- CD20 inhibitors include rituximab (Rituxan).
- JAK kinase inhibitors include tofacitinib (Xeljanz), baricitinib (Olumiant), and upadacitinib (Rinvoq).
- Each class targets specific molecules or pathways involved in rheumatoid arthritis inflammation.
- The video provides examples of brand and generic names for each medication class.
- These biologics are used to manage symptoms and progression of rheumatoid arthritis.
- The transcript contains some transcription errors but the key medication names and classes are clear.











